BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $299,391 | -23.6% | 5,874 | -19.3% | 0.01% | -31.6% |
| Q3 2022 | $392,000 | -32.2% | 7,280 | -19.1% | 0.02% | -32.1% |
| Q2 2022 | $578,000 | -24.9% | 8,998 | +0.3% | 0.03% | -12.5% |
| Q4 2021 | $770,000 | +4.8% | 8,967 | -1.9% | 0.03% | -8.6% |
| Q3 2021 | $735,000 | +1.1% | 9,141 | +1.7% | 0.04% | -2.8% |
| Q2 2021 | $727,000 | -8.4% | 8,985 | -12.0% | 0.04% | -20.0% |
| Q1 2021 | $794,000 | +14.4% | 10,213 | +13.1% | 0.04% | -10.0% |
| Q4 2020 | $694,000 | -2.9% | 9,031 | +1.5% | 0.05% | -21.9% |
| Q3 2020 | $715,000 | -9.5% | 8,901 | -4.0% | 0.06% | -19.0% |
| Q2 2020 | $790,000 | +4.1% | 9,273 | -0.8% | 0.08% | -22.5% |
| Q1 2020 | $759,000 | -88.2% | 9,347 | +15.1% | 0.10% | -87.4% |
| Q4 2019 | $6,447,000 | +885.8% | 8,124 | +8.7% | 0.81% | +684.5% |
| Q3 2019 | $654,000 | 0.0% | 7,474 | -6.4% | 0.10% | -6.4% |
| Q2 2019 | $654,000 | -9.2% | 7,983 | -9.9% | 0.11% | +0.9% |
| Q1 2019 | $720,000 | +19.4% | 8,858 | -3.3% | 0.11% | -17.4% |
| Q4 2018 | $603,000 | +43.2% | 9,161 | +67.9% | 0.13% | +55.3% |
| Q3 2018 | $421,000 | +5.5% | 5,457 | +1.0% | 0.08% | -10.5% |
| Q2 2018 | $399,000 | +16.7% | 5,405 | +2.9% | 0.10% | +11.8% |
| Q1 2018 | $342,000 | +43.7% | 5,253 | +42.5% | 0.08% | 0.0% |
| Q4 2017 | $238,000 | +3.0% | 3,686 | +0.1% | 0.08% | -16.7% |
| Q3 2017 | $231,000 | +3.6% | 3,683 | +0.1% | 0.10% | -11.3% |
| Q2 2017 | $223,000 | +5.2% | 3,681 | -9.8% | 0.12% | -8.7% |
| Q1 2017 | $212,000 | – | 4,079 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |